Showing results (251-260 of 646) with videos related to
Sort By:
Pageof 65
American Heart Journal|March 25, 2014
Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery: a meta-analysis of 1,190 patientsRalf E Harskamp, Akshay Bagai, Michael E Halkos, et al.Circulation. Arrhythmia and Electrophysiology|January 28, 2022
Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic DevicesDerek S Chew, Zhen Li, Benjamin A Steinberg, et al.Journal of the American College of Cardiology|September 29, 2018
Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID TrialIris Baumgartner, Lars Norgren, F Gerry R Fowkes, et al.Journal of Vascular Surgery|January 24, 2024
Psychosocial and socioeconomic factors are most predictive of health status in patients with claudicationLindsey E Scierka, Poghni A Peri-Okonny, Gaelle Romain, et al.Circulation. Cardiovascular Quality and Outcomes|May 12, 2012
Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDRSteven M Bradley, Paul S Chan, John A Spertus, et al.ESC Heart Failure|May 13, 2026
Characterisation of Incident Heart Failure after Ischaemic Stroke/Transient Ischaemic Attack: A UK Biobank StudyRahul G Muthalaly, Nitesh Nerlekar, Sean Tan, et al.Computer Methods and Programs in Biomedicine|July 21, 2020
Fluid structure interaction modelling of aortic valve stenosis: Effects of valve calcification on coronary artery flow and aortic root hemodynamicsAraz R Kivi, Nima Sedaghatizadeh, Benjamin S Cazzolato, et al.Frontiers in Cardiovascular Medicine|August 5, 2022
Understanding Study Drug Discontinuation Through EUCLIDE Hope Weissler, Hillary Mulder, Frank W Rockhold, et al.JAMA|November 10, 2015
Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary InterventionNihar R Desai, Steven M Bradley, Craig S Parzynski, et al.Lancet (London, England)|April 6, 2022
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 studyJonathan P Piccini, Valeria Caso, Stuart J Connolly, et al.Pageof 65